01 January 2005
Imatinib mesylate induced severe bone marrow aplasia in a patient with long duration of chronic myelogenous leukemia treated previously with busulphan and hydroxyureaTadeusz Robak, Krzysztof Jamroziak, Agnieszka Janus, Adam Hołub, Halina Urbańska-Ryś, Ewa Wawrzyniak, Dorota Kupnicka, Joanna Góra-Tybor
Case Rep Clin Pract Rev 2005; 6:332-336 :: ID: 440493
Background: Myelosuppresion is a relatively common side effect of imatinib mesylate (IM) therapy of chronic myelogenous leukemia (CML), although sustained severe bone marrow aplasia has rarely been
Case Report: Here, we describe a 76-year-old woman with a 15-year history of CML treated formerly with
busulfan and hydroxyurea, who developed severe bone marrow aplasia following treatment with IM. The patient was started on IM at a dose of 300 mg daily, when her disease progressed to the accelerated phase. She responded well to treatment by entering the second chronic phase of CML. However, after six months of IM therapy she developed profound pancytopenia. The histopathological examination of bone marrow revealed total aplasia without any haematopoietic cells. Despite the interruption of IM, hematopoiesis did not regenerated. The patient needed
filgrastim treatment and became red blood cells and platelets transfusion dependent. Finally,
the patient recovered from pancytopenia, and actually she is in good general condition with
haematological parameters within normal range.
Conclusions: Based on this observation and other reports, we hypothesize that long duration of CML, advanced phase of the disease and previous treatment, especially with busulphan, may increase the risk of
severe bone marrow aplasia as adverse event of IM therapy.
Keywords: imatinib, chronic myelocytic leukemia, bone marrow aplasia
19 May 2022 : Case reportBilateral Emphysematous Pyelonephritis Associated with COVID Pneumonia: A Case Report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936370
17 May 2022 : Case reportHigh-Frequency Oscillatory Ventilation for Refractory Hypoxemia in Severe COVID-19 Pneumonia: A Small Case ...
Am J Case Rep In Press; DOI: 10.12659/AJCR.936651
13 May 2022 : Case reportA case of exacerbation of haloperidol-induced rhabdomyolysis following the onset of COVID-19
Am J Case Rep In Press; DOI: 10.12659/AJCR.936589
20 May 2022 : Case reportDiagnostic Puzzle of Acute Ischemic Stroke Mimics – Seizure Versus Post-Stroke Recrudescence: A Case Report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936826
19 May 2022 : Case reportExtremes of Anemia: The Lowest Hemoglobin Values Probably Ever Reported in the Pediatric Literature Attribu...
Am J Case Rep In Press; DOI: 10.12659/AJCR.936252
19 May 2022 : Case reportAcute Hepatitis with Positive Autoantibodies: A Case of Natalizumab-Induced Early-Onset Liver Injury
Am J Case Rep In Press; DOI: 10.12659/AJCR.936318
Most Viewed Current Articles
31 Dec 1969 : Case reportPenile Necrosis Associated with Local Intravenous Injection of Cocaine
Am J Case Rep 2022; 23:e935250
31 Dec 1969 : Case reportMyocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of P...
Am J Case Rep 2022; 23:e934399
31 Dec 1969 : Case reportLipedema Can Be Treated Non-Surgically: A Report of 5 Cases
Am J Case Rep 2021; 22:e934406